Telehealth for Medicare started during the pandemic and became popular quickly. But the shutdown put an abrupt halt to payments for the service.

Learn about the biggest Medicare changes coming in 2026, from rising premiums to new drug caps and coverage rules, so you can plan your retirement wisely.

The Danish pharmaceutical giant Novo Nordisk has struck an agreement with the Centers for Medicare & Medicaid Services (CMS) to set a negotiated price for

Taxpayers spent $494 billion on Medicare Advantage last year. The Medicare Payment Advisory Commission, the independent body of experts that advises Congress on the program, estimates that it costs taxpayers 20% more to provide insurance to a retiree through Medicare Advantage than it would through traditional, government-run Medicare.

Seniors could soon pay just $50 a month for Ozempic and other drugs used for weight loss under a new Trump plan to cut prescription costs.

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new pricing initiative.

The government shutdown has delayed the usual release of the 2026 Medicare home health final rule, leaving providers in limbo. As they await clarity, many

The one-year contract agreement resolves an impasse that could have blocked 33,000 patients from their health care providers.

Two House members -- Richard Neal (D-Mass.) and Frank Pallone (D-N.J.) -- sent a separate letter to Oz and HHS Secretary Robert F. Kennedy Jr. stating the directory is "deeply flawed and inaccurate."

The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned with those paid in other countries, known as most-favored-nation pricing.

Under the arrangement, prices for GLP-1 drugs—used both for diabetes and obesity—will be slashed for Medicare and Medicaid beneficiaries. The prices of Ozempic and Wegovy will fall from $1,000 and $1,